Patients with JIA-associated uveitis who discontinued adalimumab had higher recurrence rates than those who continued the treatment, but they regained control upon restarting it.

Kate Myrna, DVM, DACVO, discussed the ophthalmologic condition during a session at the 2025 Veterinary Meeting & Expo.